KRAS and lung adenocarcinoma: Using anti-mutant KRAS-siRNA, and siGLO-green as our model siRNAs, we hoped to verify the involvement of NTSR1 in the internalization of siRNA-loaded hybrid nanoparticles in A549 and H23 lung adenocarcinoma cell lines.